Status:
COMPLETED
Role of MRI in Diagnosis of Pulmonary Embolism
Lead Sponsor:
Assiut University
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this work is to emphasize the role of non-contrast MR imaging in diagnosis of acute pulmonary embolism in comparison to CTA and contrast enhanced MRA as gold standard techniques.
Detailed Description
Pulmonary embolism (PE) is a serious condition responsible for significant morbidity and mortality. PE is currently the third leading cause of cardiovascular death worldwide, so it requires prompt dia...
Eligibility Criteria
Inclusion
- High clinical probability of PE assessed by the revised Geneva score and / or had a D- dimer level \> 500 µg L1 on an ELISA-based test
- Patients with clinically evident and confirmed by CT PA or contrast enhanced MR-PA to have PE .
- Both sexes will be included in addition to pregnant women.
- No age predilection but children Less than 18 years old will not be included
Exclusion
- Patients known to have contraindication for MRI, e.g. an implanted magnetizable device, metallic ocular implant, pacemakers, or claustrophobia.
- Patients with bad general condition with signs of a severe PE such as unstable haemodynamic.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03754673
Start Date
December 1 2018
End Date
April 30 2020
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hossam Mohammed Mostafa
Asyut, Egypt, 020